Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy

Cancer

Volumn 118, Issue 17, 2012, Pages 4148-4155

  Ahmed, Hashim Uddin ^a,b   Cathcart, Paul ^b,c   McCartan, Neil ^b   Kirkham, Alex ^b   Allen, Clare ^b   Freeman, Alex ^b   Emberton, Mark ^a,b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

Author keywords

external beam radiotherapy; focal; high intensity focused ultrasound; prostate cancer; salvage

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BIOCHEMICAL FAILURE FREE SURVIVAL; BIOPSY; CANCER CONTROL; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEASIBILITY STUDY; FOLLOW UP; FUNCTIONAL ASSESSMENT; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HUMAN TISSUE; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MALE; MULTIPARAMETRIC NUCLEAR MAGNETIC RESONANCE IMAGING; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; QUESTIONNAIRE; RADIATION DOSE FRACTIONATION; RECTOURETHRAL FISTULA; REGISTER; SAFETY; SALVAGE THERAPY; SURVIVAL RATE; UNIVERSITY OF CALIFORNIA LOS ANGELES EXPANDED PROSTATE CANCER INDEX COMPOSITE URINARY DOMAIN; URETHRA FISTULA; URINARY DIVERSION;

AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TREATMENT OUTCOME; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 84865321587     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27394     Document Type: Article

References (30)

1. Bannuru RR, Dvorak T, Obadan N, et al. Comparative evaluation of radiation treatments for clinically localized prostate cancer: an updated systematic review. Ann Intern Med. 2011; 155: 171-178.
2. Zelefsky MJ, Kuban DA, Levy LB, et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys. 2007; 67: 327-333.
3. Agarwal PK, Sadetsky N, Konety BR, et al. Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE). Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer. 2008; 112: 307-314.
4. Grossfeld GD, Li YP, Lubeck DP, et al. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol. 2002; 168: 530-535.
5. Taylor LG, Canfield SE, Du XL,. Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer. Cancer. 2009; 115: 2388-2399.
6. Nguyen PL, D'Amico AV, Lee AK, Suh WW,. Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer. 2007; 110: 1417-1428.
7. Boukaram C, Hannoun-Levi JM,. Management of prostate cancer recurrence after definitive radiation therapy. Cancer Treat Rev. 2010; 36: 91-100.
8. Zacharakis E, Ahmed HU, Ishaq A, et al. The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy. BJU Int. 2008; 102: 786-792.
9. Ahmed HU, Freeman A, Kirkham A, et al. Focal therapy in men with localised prostate cancer: a phase I/II trial. J Urology. 2011; 185: 1246-1254.
10. Eisenberg ML, Shinohara K,. Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. Urology. 2008; 72: 1315-1318.
11. Gowardhan B, Greene D,. Salvage cryotherapy: is there a role for focal therapy? J Endourol. 2010; 24: 861-864.
12. Huang WC, Kuroiwa K, Serio AM, et al. The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies. J Urol. 2007; 177: 1324-1329.
13. Pucar D, Hricak H, Shukla-Dave A, et al. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. Int J Radiat Oncol Biol Phys. 2007; 69: 62-69.
14. Cellini N, Morganti AG, Mattiucci GC, et al. Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning. Int J Radiat Oncol Biol Phys. 2002; 53: 595-599.
15. Arakawa A, Song S, Scardino PT, Wheeler TM,. High grade prostatic intraepithelial neoplasia in prostates removed following irradiation failure in the treatment of prostatic adenocarcinoma. Pathol Res Pract. 1995; 191: 868-872.
16. Cheng L, Cheville JC, Pisansky TM, et al. Prevalence and distribution of prostatic intraepithelial neoplasia in salvage radical prostatectomy specimens after radiation therapy. Am J Surg Pathol. 1999; 23: 803-808.
17. Ahmed HU, Pendse D, Illing R, et al. Will focal therapy become a standard of care for men with localized prostate cancer? Nat Clin Pract Oncol. 2007; 4: 632-642.
18. Roach M 3rd,. Primary focal unilateral nerve-sparing cryoablation for very early prostate cancer: is it enough or too much, or do we know? Cancer J. 2010; 16: 542-543.
19. Ahmed HU,. The index lesion and the origin of prostate cancer. N Engl J Med. 2009; 361: 1704-1706.
20. Ahmed HU, Cathcart P, Chalasani V, et al. Whole-gland salvage high-intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy [published online ahead of print November 9, 2011]. Cancer. 2011.
21. Litwin MS, Hays RD, Fink A, et al. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care. 1998; 36: 1002-1012.
22. Rosen RC, Riley A, Wagner G, et al. The International Index of Erectile Function (IIEF) a multidimensional scale for assessment of erectile dysfunction. Urology. 1997; 49: 822-830.
23. Clavien PA, Sanabria JR, Strasberg SM,. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery. 1992; 111: 518-526.
24. Dindo D, Demartines N, Clavien PA,. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of surgery. Ann Surg. 2004; 240: 205-213.
25. Arumainayagam N, Kumaar S, Ahmed HU, et al. Accuracy of multiparametric magnetic resonance imaging in detecting recurrent prostate cancer after radiotherapy. BJU Int. 2010; 106: 991-997.
26. Haider MA, Chung P, Sweet J, et al. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2008; 70: 425-430.
27. Ahmed HU, Moore C, Lecornet E, Emberton M,. Focal therapy in prostate cancer: determinants of success and failure. J Endourol. 2010; 24: 819-825.
28. Pisters LL,. Treatment failure after primary and salvage therapy for prostate cancer. Cancer. 2008; 112: 225-227.
29. Onik G, Miessau M, Bostwick DG,. Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. J Clin Oncol. 2009; 27: 4321-4326.
30. Chrouser KL, Leibovich BC, Sweat SD, et al. Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer. J Urol. 2005; 173: 1953-1957.